Veracyte, Inc. (VCYT)
USD 30.35
(2.15%)
USD 30.35
(2.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -203.82 Million USD | -46.08% |
| 2022 | -139.52 Million USD | 9.6% |
| 2021 | -154.34 Million USD | 54.21% |
| 2020 | -337.04 Million USD | -131.31% |
| 2019 | -145.71 Million USD | -176.42% |
| 2018 | -52.71 Million USD | -509.75% |
| 2017 | -8.64 Million USD | 74.35% |
| 2016 | -33.7 Million USD | 1.04% |
| 2015 | -34.05 Million USD | -13.18% |
| 2014 | -30.09 Million USD | 54.63% |
| 2013 | -66.32 Million USD | -373.65% |
| 2012 | -14 Million USD | -85.06% |
| 2011 | -7.56 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -215.17 Million USD | -10.26% |
| 2023 Q1 | -176.27 Million USD | -7.42% |
| 2023 FY | -203.82 Million USD | -46.08% |
| 2023 Q4 | -195.14 Million USD | 4.26% |
| 2023 Q3 | -203.82 Million USD | -7.99% |
| 2023 Q2 | -188.73 Million USD | -7.07% |
| 2022 Q4 | -164.1 Million USD | -17.61% |
| 2022 Q2 | -153.44 Million USD | -12.94% |
| 2022 FY | -139.52 Million USD | 9.6% |
| 2022 Q1 | -135.85 Million USD | 6.44% |
| 2022 Q3 | -139.52 Million USD | 9.07% |
| 2021 Q1 | -310.35 Million USD | -1.33% |
| 2021 Q2 | -145.25 Million USD | 53.2% |
| 2021 Q4 | -145.2 Million USD | 5.92% |
| 2021 Q3 | -154.34 Million USD | -6.26% |
| 2021 FY | -154.34 Million USD | 54.21% |
| 2020 Q1 | -134.41 Million USD | 3.85% |
| 2020 FY | -337.04 Million USD | -131.31% |
| 2020 Q2 | -332.45 Million USD | -147.33% |
| 2020 Q3 | -337.04 Million USD | -1.38% |
| 2020 Q4 | -306.28 Million USD | 9.13% |
| 2019 Q2 | -181.7 Million USD | -1.86% |
| 2019 FY | -145.71 Million USD | -176.42% |
| 2019 Q1 | -178.39 Million USD | -335.87% |
| 2019 Q3 | -145.71 Million USD | 19.81% |
| 2019 Q4 | -139.8 Million USD | 4.05% |
| 2018 Q4 | -40.92 Million USD | 22.36% |
| 2018 Q3 | -52.71 Million USD | -0.26% |
| 2018 Q2 | -52.57 Million USD | -3602.66% |
| 2018 FY | -52.71 Million USD | -509.75% |
| 2018 Q1 | 1.5 Million USD | 178.88% |
| 2017 FY | -8.64 Million USD | 74.35% |
| 2017 Q3 | -8.64 Million USD | 45.34% |
| 2017 Q2 | -15.81 Million USD | 24.81% |
| 2017 Q4 | -1.9 Million USD | 77.99% |
| 2017 Q1 | -21.03 Million USD | 19.2% |
| 2016 Q2 | -6.8 Million USD | 52.46% |
| 2016 FY | -33.7 Million USD | 1.04% |
| 2016 Q1 | -14.32 Million USD | 37.74% |
| 2016 Q4 | -26.03 Million USD | 22.75% |
| 2016 Q3 | -33.7 Million USD | -395.04% |
| 2015 Q4 | -23 Million USD | 32.45% |
| 2015 Q3 | -34.05 Million USD | 17.17% |
| 2015 Q2 | -41.11 Million USD | 10.76% |
| 2015 Q1 | -46.07 Million USD | -120.97% |
| 2015 FY | -34.05 Million USD | -13.18% |
| 2014 Q4 | -20.84 Million USD | 30.71% |
| 2014 FY | -30.09 Million USD | 54.63% |
| 2014 Q3 | -30.09 Million USD | 22.83% |
| 2014 Q2 | -38.99 Million USD | 26.46% |
| 2014 Q1 | -53.02 Million USD | 10.58% |
| 2013 Q4 | -59.3 Million USD | 10.58% |
| 2013 FY | -66.32 Million USD | -373.65% |
| 2013 Q3 | -66.32 Million USD | -527.86% |
| 2013 Q2 | -10.56 Million USD | 33.39% |
| 2013 Q1 | -15.85 Million USD | -124.22% |
| 2012 Q4 | -7.07 Million USD | 49.49% |
| 2012 Q3 | -14 Million USD | 0.0% |
| 2012 FY | -14 Million USD | -85.06% |
| 2011 FY | -7.56 Million USD | 0.0% |
| 2001 Q3 | -154.34 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -180.757% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 224.005% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.9% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -270460.438% |
| Apollomics, Inc. | -27.39 Million USD | -644.019% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -30983.525% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -130.414% |
| Bicycle Therapeutics plc | -481.46 Million USD | 57.666% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -57.864% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 663.626% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5004.331% |
| Chimerix, Inc. | -25.51 Million USD | -698.777% |
| CRISPR Therapeutics AG | -150.84 Million USD | -35.121% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 214.723% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 26.096% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2759.152% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2759.152% |
| Gritstone bio, Inc. | 39.49 Million USD | 616.141% |
| Allakos Inc. | -24.97 Million USD | -716.112% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -847.534% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2160.692% |
| Cytokinetics, Incorporated | 642.37 Million USD | 131.73% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -184.103% |
| Innoviva, Inc. | 255.56 Million USD | 179.755% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2106.559% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27790.995% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -402.376% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3533.053% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -156.954% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -434.382% |
| ImmuCell Corporation | 10.99 Million USD | 1954.537% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -32.228% |
| Incyte Corporation | -3.17 Billion USD | 93.581% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1382.043% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -17054.953% |
| Mustang Bio, Inc. | -3.73 Million USD | -5355.675% |
| MiMedx Group, Inc. | -33.9 Million USD | -501.233% |
| MEI Pharma, Inc. | -3.7 Million USD | -5401.323% |
| MacroGenics, Inc. | -66.98 Million USD | -204.283% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2705.144% |
| Mereo BioPharma Group plc | -51.46 Million USD | -296.013% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1248.805% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1895.536% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 666.099% |
| Minerva Neurosciences, Inc. | 41 Million USD | 597.08% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -816.805% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7930.89% |
| NextCure, Inc. | -6.47 Million USD | -3046.889% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -605.957% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -303.604% |
| Onconetix, Inc. | 5.33 Million USD | 3923.059% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3095.234% |
| Opthea Limited | 28.15 Million USD | 823.872% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1175.009% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3056.285% |
| PDS Biotechnology Corporation | -32.7 Million USD | -523.145% |
| Precigen, Inc. | -481 Thousand USD | -42275.052% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1071.672% |
| Prime Medicine, Inc. | -27.94 Million USD | -629.48% |
| PureTech Health plc | -167.19 Million USD | -21.906% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -560.437% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -652.118% |
| Replimune Group, Inc. | 1.41 Million USD | 14535.127% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1599.709% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 833.365% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8696.79% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 66.488% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1000.57% |
| Sesen Bio, Inc. | -112.55 Million USD | -81.092% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2770.761% |
| Solid Biosciences Inc. | -47.75 Million USD | -326.857% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 30.615% |
| SciSparc Ltd. | -2.06 Million USD | -9770.412% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 279.611% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1241.104% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1246.706% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3183.247% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 158.805% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4741.858% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -747.959% |
| XOMA Corporation | -29 Million USD | -602.841% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1249.275% |
| AbCellera Biologics Inc. | -55.94 Million USD | -264.362% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1371.016% |
| Cassava Sciences, Inc. | -121.13 Million USD | -68.26% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3025.112% |
| Precision BioSciences, Inc. | -85.41 Million USD | -138.642% |
| Dyadic International, Inc. | -6.37 Million USD | -3095.686% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2327.054% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1179.257% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -569.153% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -512.875% |
| IGM Biosciences, Inc. | -72.6 Million USD | -180.726% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -394.899% |
| Acelyrin, Inc. | -216.9 Million USD | 6.03% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2146.49% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1114.033% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2285.811% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 35.659% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -163.165% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11814.023% |
| Mesoblast Limited | 55.96 Million USD | 464.212% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -705.883% |
| ChromaDex Corporation | -24.04 Million USD | -747.572% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -23543.035% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 432.736% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2640.257% |
| Seer, Inc. | -4.24 Million USD | -4707.17% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 226.018% |
| Novavax, Inc. | -298.29 Million USD | 31.67% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2129.653% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 430.529% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4036.039% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -147.119% |
| Celcuity Inc. | 6.78 Million USD | 3104.699% |
| ContextLogic Inc. | -232 Million USD | 12.145% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 15.901% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -84.394% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.44% |
| Amarin Corporation plc | -191.04 Million USD | -6.692% |
| AnaptysBio, Inc. | -18.15 Million USD | -1022.935% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1671.304% |
| Aptorum Group Limited | 1.35 Million USD | 15119.682% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -209.03% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4862.243% |
| Ardelyx, Inc. | 34.51 Million USD | 690.589% |
| Celularity Inc. | 65.19 Million USD | 412.661% |
| Omeros Corporation | 331.17 Million USD | 161.546% |
| Humacyte, Inc. | -22.48 Million USD | -806.448% |
| Immunocore Holdings plc | -358.59 Million USD | 43.16% |
| IO Biotech, Inc. | -140.69 Million USD | -44.865% |
| GT Biopharma, Inc. | -1.02 Million USD | -19863.173% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -8.29% |
| Summit Therapeutics Inc. | 34.67 Million USD | 687.829% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3262.323% |
| Pulmatrix, Inc. | -10.41 Million USD | -1856.648% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -82.963% |
| Evogene Ltd. | -19.63 Million USD | -938.118% |
| CorMedix Inc. | -43.05 Million USD | -373.431% |
| BioLineRx Ltd. | 7.33 Million USD | 2878.408% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -74.14% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -171.497% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -13.884% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3014.194% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1282.608% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -50.535% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27790.995% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1000.57% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 2.085% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -119.726% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -814.501% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -10.41% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -664.56% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1775.734% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1121.076% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3851.677% |
| bluebird bio, Inc. | 108.57 Million USD | 287.733% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 153.815% |
| DBV Technologies S.A. | -126.98 Million USD | -60.509% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -16.318% |
| Galecto, Inc. | -21.21 Million USD | -860.709% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2896.09% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -122.2% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -200.701% |
| GlycoMimetics, Inc. | -40.98 Million USD | -397.321% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 274.817% |
| ADMA Biologics, Inc. | 90.06 Million USD | 326.305% |
| Clene Inc. | 3.34 Million USD | 6202.515% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 40.77% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2387.219% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6413.993% |
| Soligenix, Inc. | -4.95 Million USD | -4016.329% |
| Century Therapeutics, Inc. | 847 Thousand USD | 24164.227% |
| Kura Oncology, Inc. | -20.11 Million USD | -913.142% |
| Surrozen, Inc. | -32.66 Million USD | -524.002% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -398.031% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 11288.701% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6275.477% |
| Autolus Therapeutics plc | -186.59 Million USD | -9.231% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -313.403% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 694.794% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -760.852% |
| GRI Bio, Inc. | -1.79 Million USD | -11261.427% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2168.985% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3919.074% |
| INmune Bio, Inc. | -25.41 Million USD | -702.109% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 235.027% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -302.345% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1154.35% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2093.725% |
| Jaguar Health, Inc. | 29.39 Million USD | 793.491% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6965.138% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 636.167% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1547.511% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 739.247% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 153.929% |
| Verastem, Inc. | -37.27 Million USD | -446.768% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -293.012% |
| Histogen Inc. | -7.48 Million USD | -2622.372% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -843.332% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -55.056% |
| Surrozen, Inc. | -32.66 Million USD | -524.002% |
| Organovo Holdings, Inc. | -1.5 Million USD | -13425.149% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4748.925% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2331.934% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -369.187% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1298.271% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -28128.125% |
| Kronos Bio, Inc. | -36.05 Million USD | -465.33% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1297.586% |
| Synaptogenix, Inc. | -28.66 Million USD | -611.142% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -21676.068% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 32556.051% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 518.255% |
| Exelixis, Inc. | -73.05 Million USD | -179.02% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -748.807% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 15.556% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -142.356% |
| ESSA Pharma Inc. | -33.62 Million USD | -506.23% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7643.661% |
| Avid Bioservices, Inc. | 169.72 Million USD | 220.089% |
| Insmed Incorporated | 721.62 Million USD | 128.245% |
| MediWound Ltd. | -5.32 Million USD | -3729.838% |
| OmniAb, Inc. | 9.2 Million USD | 2314.756% |
| Alector, Inc. | -35.63 Million USD | -471.945% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 337.085% |
| Zai Lab Limited | -775 Million USD | 73.7% |
| AlloVir, Inc. | -62.69 Million USD | -225.12% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 159.851% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1447.521% |
| Aura Biosciences, Inc. | -21.52 Million USD | -846.918% |
| Immunic, Inc. | -45.34 Million USD | -349.546% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -5.491% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 131.933% |
| FibroGen, Inc. | 56.76 Million USD | 459.054% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2388.871% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -52.018% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -7109.695% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9744.915% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6000.688% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -22.812% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.987% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -732.887% |
| XBiotech Inc. | -200.02 Million USD | -1.9% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -142.356% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 35.642% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11722.738% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4601.413% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -478.011% |
| Agenus Inc. | 274.13 Million USD | 174.351% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -163.959% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3681.515% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -19.604% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -120.651% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 127.683% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1792.947% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -266.498% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5803.368% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2170.753% |
| Lantern Pharma Inc. | -21.7 Million USD | -839.139% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4719.674% |
| Ainos, Inc. | 4.07 Million USD | 5098.225% |
| Pluri Inc. | 22.82 Million USD | 992.829% |
| Prothena Corporation plc | -608.34 Million USD | 66.495% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -71.633% |
| Rallybio Corporation | -24.1 Million USD | -745.673% |
| Kodiak Sciences Inc. | -103.87 Million USD | -96.22% |
| Cue Biopharma, Inc. | -33.81 Million USD | -502.691% |
| MeiraGTx Holdings plc | -40.3 Million USD | -405.742% |
| Annexon, Inc. | -193.75 Million USD | -5.197% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1064.775% |
| Moderna, Inc. | -2.9 Billion USD | 92.989% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -729.396% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -559.603% |
| Blueprint Medicines Corporation | 702.83 Million USD | 129.0% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1064.057% |
| CalciMedica, Inc. | -5.53 Million USD | -3585.787% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -148.378% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -409.089% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -21.156% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -512.949% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3310.139% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -240.024% |
| Nutriband Inc. | -251.65 Thousand USD | -80892.78% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -497.391% |
| Vor Biopharma Inc. | 4.3 Million USD | 4840.093% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.623% |
| Alkermes plc | -166.73 Million USD | -22.241% |
| ProKidney Corp. | -56.23 Million USD | -262.444% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -318.771% |
| Arcellx, Inc. | -296.95 Million USD | 31.363% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.944% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -642.123% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 541.684% |
| Atai Life Sciences N.V. | -28.55 Million USD | -613.719% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 9237.922% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -793.338% |
| MediciNova, Inc. | -50.78 Million USD | -301.359% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -158.643% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -905985.797% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3058.794% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -2.003% |
| Biomea Fusion, Inc. | -166.57 Million USD | -22.365% |
| RenovoRx, Inc. | -1.17 Million USD | -17276.3% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -114.904% |
| Geron Corporation | 14.76 Million USD | 1480.828% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4563.951% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 13.058% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -116.348% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -112.991% |
| Royalty Pharma plc | 5.65 Billion USD | 103.602% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -421.649% |
| Imunon, Inc. | -4.21 Million USD | -4736.999% |
| BioAtla, Inc. | -109.01 Million USD | -86.976% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1803.36% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -861.298% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -44.832% |
| Structure Therapeutics Inc. | -124.33 Million USD | -63.926% |
| 89bio, Inc. | -289.05 Million USD | 29.486% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1130.821% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2636.26% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -63.535% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -149.238% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -23622.974% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5201.014% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12659.323% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 114.76% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 343.812% |
| Liquidia Corporation | -80.17 Million USD | -154.221% |
| Entera Bio Ltd. | -10.62 Million USD | -1817.622% |
| GH Research PLC | -78.07 Million USD | -161.055% |
| Vericel Corporation | 1.27 Million USD | 16061.159% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1060.465% |
| Xencor, Inc. | 29.64 Million USD | 787.573% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -10247.383% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1154.35% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -83124.721% |
| Vaxcyte, Inc. | -368.22 Million USD | 44.647% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -47.977% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -61.231% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -17054.953% |
| Portage Biotech Inc. | -4.98 Million USD | -3992.03% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -905985.797% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -208.254% |
| OncoCyte Corporation | -6.56 Million USD | -3005.653% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 22812.397% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4374.099% |
| Purple Biotech Ltd. | -14.13 Million USD | -1341.675% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -997.657% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3378.225% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -246.516% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -757.99% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -787.117% |
| United Therapeutics Corporation | -507.7 Million USD | 59.853% |
| HilleVax, Inc. | -165.48 Million USD | -23.168% |
| Silo Pharma, Inc. | -3.52 Million USD | -5683.376% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 204395.924% |
| Pharming Group N.V. | 109.8 Million USD | 285.625% |
| Tharimmune, Inc. | -10.93 Million USD | -1763.9% |
| Genprex, Inc. | -6.73 Million USD | -2925.159% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -75.284% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 44.734% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2099.255% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -14448.465% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6044.93% |
| OKYO Pharma Limited | -826.84 Thousand USD | -24550.722% |
| Savara Inc. | 153 Thousand USD | 133318.301% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1729.158% |
| Curis, Inc. | -23.88 Million USD | -753.284% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -26165.573% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 17300.338% |
| BeiGene, Ltd. | -2.25 Billion USD | 90.954% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -9.827% |
| Erasca, Inc. | -37.21 Million USD | -447.678% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15726.159% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15726.159% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1868.934% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1775.451% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -549.721% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -531.582% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -492.925% |
| Adicet Bio, Inc. | -138.78 Million USD | -46.861% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 202.908% |
| Aditxt, Inc. | 18.12 Million USD | 1224.802% |
| Adagene Inc. | -87.62 Million USD | -132.603% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4793.231% |
| Quantum-Si incorporated | -118.55 Million USD | -71.921% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2627.039% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -320.178% |
| Compugen Ltd. | -12.9 Million USD | -1479.541% |
| Generation Bio Co. | 31.44 Million USD | 748.13% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -16.229% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -559.134% |
| Invivyd, Inc. | -198.47 Million USD | -2.695% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -125.794% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -8400.855% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -187.928% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2886.432% |
| 2seventy bio, Inc. | 181.71 Million USD | 212.167% |
| Instil Bio, Inc. | 75.35 Million USD | 370.474% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2144.09% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6440.447% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3058.794% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -683.948% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4881.563% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3812.92% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -56.422% |
| Evaxion Biotech A/S | 5.28 Million USD | 3955.306% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -81.067% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -55.267% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -295.698% |
| Cingulate Inc. | 3.08 Million USD | 6711.903% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6839.871% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2936.009% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -93.121% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5069.738% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2266.266% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14078.481% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -275.671% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1279.674% |
| ImmunityBio, Inc. | 618.22 Million USD | 132.969% |
| Korro Bio, Inc. | -132.94 Million USD | -53.317% |
| Kineta, Inc. | -4.54 Million USD | -4388.527% |
| BioVie Inc. | -17.73 Million USD | -1049.447% |
| Codexis, Inc. | -43.27 Million USD | -371.041% |
| Celularity Inc. | 65.19 Million USD | 412.661% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 374.992% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6331.808% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5957.278% |
| Cibus, Inc. | -8.07 Million USD | -2423.199% |
| IN8bio, Inc. | -16.38 Million USD | -1143.663% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 566277.778% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5701.993% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 119.333% |
| Eyenovia, Inc. | 1.25 Million USD | 16293.189% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 857.569% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6185.045% |
| Elevation Oncology, Inc. | -19.11 Million USD | -966.137% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -513.06% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -944.93% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -246.198% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -883.374% |
| Moolec Science SA | 117.61 Thousand USD | 173396.15% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -430.805% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -437.539% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -44.126% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -806.086% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2816.177% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3700.659% |
| Humacyte, Inc. | -22.48 Million USD | -806.448% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -707.48% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -11331.52% |
| Genelux Corporation | -6.89 Million USD | -2854.399% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -556.248% |
| Notable Labs, Ltd. | -9.77 Million USD | -1984.943% |
| Immunovant, Inc. | -635.22 Million USD | 67.913% |
| Quantum-Si incorporated | -118.55 Million USD | -71.921% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4819.72% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2639.23% |
| Acasti Pharma Inc. | -23 Million USD | -785.999% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5953.167% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -20.408% |
| PepGen Inc. | -60.67 Million USD | -235.955% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -965.691% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -23543.035% |
| Immuneering Corporation | -54.94 Million USD | -270.975% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4748.925% |
| Belite Bio, Inc | -87.27 Million USD | -133.553% |
| XOMA Corporation | -29 Million USD | -602.841% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -188.306% |
| Bionomics Limited | 227 Million USD | 189.786% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7946.743% |
| uniQure N.V. | -102.95 Million USD | -97.982% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4793.231% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 597.727% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1604.072% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6487.292% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 192386.792% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6185.045% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2388.871% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2648.436% |
| Altimmune, Inc. | -134.48 Million USD | -51.557% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -9.879% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7946.743% |
| Peak Bio, Inc. | 10.34 Million USD | 2071.188% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -71922.615% |
| Benitec Biopharma Inc. | -50.58 Million USD | -302.958% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -95.35% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1137.536% |
| Zura Bio Limited | -99.8 Million USD | -104.22% |
| PolyPid Ltd. | 6.17 Million USD | 3403.468% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1137.536% |
| argenx SE | -2.02 Billion USD | 89.954% |
| Immunome, Inc. | -97.02 Million USD | -110.065% |
| Verona Pharma plc | -220.44 Million USD | 7.539% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -184.103% |
| Shattuck Labs, Inc. | -121.42 Million USD | -67.861% |
| CervoMed Inc. | -7.79 Million USD | -2515.527% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4560.965% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -54.717% |
| Moolec Science SA | 117.61 Thousand USD | 173396.15% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8808.481% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1022.997% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -189.601% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1914.672% |
| Achilles Therapeutics plc | -126.92 Million USD | -60.587% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14078.481% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2639.57% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 159.914% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 958.749% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 54.45% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -45.266% |
| Beam Therapeutics Inc. | -262.72 Million USD | 22.418% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1034.287% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4076.721% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -264.858% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -104.11% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8581.515% |
| NeurAxis, Inc. | 145.7 Thousand USD | 139992.931% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -422.277% |
| Lumos Pharma, Inc. | -28.49 Million USD | -615.348% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -881.158% |
| Palisade Bio, Inc. | -12.06 Million USD | -1589.663% |
| Nutriband Inc. | -251.65 Thousand USD | -80892.78% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -144.74% |
| Neurogene Inc. | -131.95 Million USD | -54.465% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4052.047% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 45.963% |
| Athira Pharma, Inc. | -88.99 Million USD | -129.018% |
| HCW Biologics Inc. | 2.85 Million USD | 7235.006% |
| XOMA Corporation | -29 Million USD | -602.841% |
| Nektar Therapeutics | 210.24 Million USD | 196.948% |
| Arvinas, Inc. | -313.8 Million USD | 35.047% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12659.323% |
| Merus N.V. | -192.88 Million USD | -5.672% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 439.792% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2837.792% |
| Rezolute, Inc. | -68.16 Million USD | -199.002% |
| Clene Inc. | 3.34 Million USD | 6202.515% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1445.643% |
| BeyondSpring Inc. | -13.75 Million USD | -1381.818% |
| Synlogic, Inc. | -6.68 Million USD | -2948.975% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 18073.898% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2310.692% |
| Peak Bio, Inc. | 10.34 Million USD | 2071.188% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -147.299% |
| Krystal Biotech, Inc. | -350.23 Million USD | 41.803% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 264.209% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -20.609% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6355.961% |
| MannKind Corporation | 143.89 Million USD | 241.644% |
| Ikena Oncology, Inc. | -109.15 Million USD | -86.727% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2592.167% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -515.782% |
| Gossamer Bio, Inc. | 180.35 Million USD | 213.013% |
| CohBar, Inc. | -5.93 Million USD | -3336.743% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -585.169% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4563.951% |
| Legend Biotech Corporation | -949.39 Million USD | 78.531% |
| Mural Oncology plc | -255.84 Million USD | 20.332% |
| Disc Medicine, Inc. | -358.28 Million USD | 43.111% |
| Champions Oncology, Inc. | 4.81 Million USD | 4335.744% |
| REGENXBIO Inc. | 54.76 Million USD | 472.159% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -75697.209% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -34.961% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2161.694% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -152.623% |
| Vaxart, Inc. | -8.24 Million USD | -2373.292% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -306.186% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -60.282% |
| Cellectis S.A. | -43.85 Million USD | -364.768% |
| Longeveron Inc. | -2.9 Million USD | -6909.078% |
| Repare Therapeutics Inc. | -107.85 Million USD | -88.974% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 121.048% |
| Inozyme Pharma, Inc. | 12 Million USD | 1797.967% |
| Revolution Medicines, Inc. | -608.2 Million USD | 66.488% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -16471.057% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 23.119% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -35.817% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1202.639% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -27443.784% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.869% |
| Denali Therapeutics Inc. | -74.86 Million USD | -172.255% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1599.709% |
| Veru Inc. | 4.77 Million USD | 4364.128% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1712.413% |
| Cingulate Inc. | 3.08 Million USD | 6711.903% |
| Passage Bio, Inc. | 4.58 Million USD | 4545.453% |
| Context Therapeutics Inc. | -14.44 Million USD | -1310.564% |
| Exicure, Inc. | 5.84 Million USD | 3584.767% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 11.526% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -415.097% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1398.987% |
| Nuvalent, Inc. | -335.38 Million USD | 39.227% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11852.245% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -173.655% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2192.733% |
| OmniAb, Inc. | 9.2 Million USD | 2314.756% |
| Anew Medical, Inc. | 1.43 Million USD | 14328.899% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1344.213% |
| Lipocine Inc. | -4.75 Million USD | -4186.887% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -85.585% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1438.218% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -302.345% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 918.833% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2932.644% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -209.636% |
| Ocugen, Inc. | -32.52 Million USD | -526.746% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -138.182% |
| Q32 Bio Inc. | -37.94 Million USD | -437.114% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -32356.051% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1406.571% |
| Equillium, Inc. | -22.39 Million USD | -810.254% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -697.184% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -524.714% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -82115.275% |
| Dominari Holdings Inc. | 195 Thousand USD | 104625.128% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3769.897% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2185.791% |
| Bio-Techne Corporation | 267.74 Million USD | 176.126% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1157.474% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -72.595% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2325.61% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1511.13% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 16.847% |
| Nkarta, Inc. | 57.29 Million USD | 455.72% |
| BioCardia, Inc. | 212 Thousand USD | 96243.396% |
| Iterum Therapeutics plc | 13.43 Million USD | 1616.773% |